Manufacturing site

Facilities - Mahad INDIA - Manufacturing site

Fermentation and Synthesis plant

Fermentation Capacity: 400 m3
Synthesis Capacity: 170 m3
Employees: about 260
Pilot plant


  • Postpartum hemorrhage
  • Tuberculosis
  • Anti-bacterial
  • Anti-psychotic
  • Anti-depressant
  • Organ preservation
  • Antacid


  • Production of rifamycin O and S, key raw materials for the production of the Rifa products, consolidated part of the OLON Group portfolio
  • Integration of synthesis and fermentation

Regulatory inspections

This facility is regularly inspected by the most important national and foreign medicine agencies.
2017API India